Effect of verapamil on catecholamine secretion by human pheochromocytoma.

Abstract

HomeHypertensionVol. 8, No. 9Effect of verapamil on catecholamine secretion by human pheochromocytoma. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBEffect of verapamil on catecholamine secretion by human pheochromocytoma. M Mannelli, M L DeFeo, M Maggi, P Geppetti, E Baldi, C Pupilli and M Serio M MannelliM Mannelli Search for more papers by this author , M L DeFeoM L DeFeo Search for more papers by this author , M MaggiM Maggi Search for more papers by this author , P GeppettiP Geppetti Search for more papers by this author , E BaldiE Baldi Search for more papers by this author , C PupilliC Pupilli Search for more papers by this author and M SerioM Serio Search for more papers by this author Originally published1 Sep 1986https://doi.org/10.1161/01.HYP.8.9.813Hypertension. 1986;8:813–814"Effect of verapamil on catecholamine secretion by human pheochromocytoma.." Hypertension, 8(9), pp. 813–814 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Mazza A, Armigliato M, Marzola M, Schiavon L, Montemurro D, Vescovo G, Zuin M, Chondrogiannis S, Ravenni R, Opocher G, Colletti P and Rubello D (2013) Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features, Endocrine, 10.1007/s12020-013-0007-y, 45:3, (469-478), Online publication date: 1-Apr-2014. Siddiqi H, Yang H, Laird A, Fox A, Doherty G, Miller B and Gauger P (2012) Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas, Surgery, 10.1016/j.surg.2012.08.023, 152:6, (1027-1036), Online publication date: 1-Dec-2012. MANNELLI M (2006) Management and Treatment of Pheochromocytomas and Paragangliomas, Annals of the New York Academy of Sciences, 10.1196/annals.1353.044, 1073:1, (405-416), Online publication date: 1-Aug-2006. Kinney M, Narr B and Warner M (2002) Perioperative management of pheochromocytoma, Journal of Cardiothoracic and Vascular Anesthesia, 10.1053/jcan.2002.124150, 16:3, (359-369), Online publication date: 1-Jun-2002. Akpunonu B, Mulrow P and Hoffman E (1996) Secondary hypertension: Evaluation and treatment, Disease-a-Month, 10.1016/S0011-5029(96)90019-X, 42:10, (609-722), Online publication date: 1-Oct-1996. Hsu T, Lee C and Kuo C (1993) Diagnostic use of metoclopramide in hypertension caused by pheochromocytoma, International Journal of Cardiology, 10.1016/0167-5273(93)90105-P, 42:1, (79-86), Online publication date: 1-Nov-1993. Greene J and Guay A (1989) New Perspectives in Pheochromocytoma, Urologic Clinics of North America, 10.1016/S0094-0143(21)01831-0, 16:3, (487-503), Online publication date: 1-Aug-1989. Sheps S, Jiang N and Klee G (1988) Diagnostic Evaluation of Pheochromocytoma, Endocrinology and Metabolism Clinics of North America, 10.1016/S0889-8529(18)30426-2, 17:2, (397-414), Online publication date: 1-Jun-1988. Doyle A (1989) Calcium Channel Blocking Drugs as Antihypertensive Agents International Yearbook of Nephrology 1989, 10.1007/978-1-4613-1673-2_5, (89-113), . September 1986Vol 8, Issue 9 Advertisement Article InformationMetrics Copyright © 1986 by American Heart Associationhttps://doi.org/10.1161/01.HYP.8.9.813PMID: 3744473 Originally publishedSeptember 1, 1986 PDF download Advertisement